Liver Resection for Metastatic Colorectal Cancer in Patients with Concurrent Extrahepatic Disease: Results in 127 Patients Treated at a Single Center

被引:111
作者
Carpizo, Darren R. [1 ]
Are, Chandrakanth [2 ]
Jarnagin, William [3 ]
DeMatteo, Ronald [3 ]
Fong, Yuman [3 ]
Goenen, Mithat [4 ]
Blumgart, Leslie [3 ]
D'Angelica, Michael [3 ]
机构
[1] Robert Wood Johnson Univ Med Sch, Div Surg Oncol, Canc Inst New Jersey, New Brunswick, NJ USA
[2] Univ Nebraska Med Ctr, Eppley Canc Ctr, Div Surg Oncol, Omaha, NE USA
[3] Mem Sloan Kettering Canc Ctr, Dept Surg, Hepatopancreatobiliary Serv, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
关键词
HEPATIC RESECTION; RADIOFREQUENCY ABLATION; RECURRENCE; SURVIVAL; OUTCOMES;
D O I
10.1245/s10434-009-0521-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Surgical resection for patients with hepatic and extrahepatic (EHD) colorectal metastases is controversial. We analyzed our experience with hepatic resection in patients with concomitant EHD. The aims were to characterize survival, recurrence rates, and factors associated with outcome. From 1992 to 2007, 1,369 patients underwent resection of hepatic colorectal metastases, of whom 127 (9%) had concurrent resection of EHD. Survival and recurrence were compared between patients with and without EHD. Survival data were stratified by site of metastatic involvement. Variables potentially associated with survival were analyzed in univariate and multivariate analyses. Median follow-up was 24 months (range 3-152 months). The 3- and 5-year survival for patients with concomitant EHD were 47% and 26%, respectively, compared with 67% and 49%, for those without EHD (P < 0.001). Among the patients with EHD, multivariate analysis identified higher clinical risk score, incomplete resection of all EHD, EHD detected intraoperatively, and having received neoadjuvant chemotherapy to be independently associated with a worse survival. Patients with portal lymph node metastases had worse survival than those with lung or ovarian metastases. Among patients who had a complete resection of all disease, 95% recurred. Concurrent resection of hepatic and EHD in well-selected patients is associated with a possibility of long-term survival. The presence of limited and resectable EHD should not be an absolute contraindication to resection. The site of EHD and the nearly universal recurrence rate must be taken into consideration.
引用
收藏
页码:2138 / 2146
页数:9
相关论文
共 15 条
  • [1] Abdalla EK, 2004, ANN SURG, V239, P818, DOI 10.1097/01.sla.0000128305.90650.71
  • [2] ADSON MA, 1984, ARCH SURG-CHICAGO, V119, P647
  • [3] Blumgart L H, 1995, Curr Probl Surg, V32, P333
  • [4] Trends in long-term survival following liver resection for hepatic colorectal metastases
    Choti, MA
    Sitzmann, JV
    Tiburi, MF
    Sumetchotimetha, W
    Rangsin, R
    Schulick, RD
    Lillemoe, KD
    Yeo, CJ
    Cameron, JL
    [J]. ANNALS OF SURGERY, 2002, 235 (06) : 759 - 765
  • [5] DETERMINANTS OF SURVIVAL IN LIVER RESECTION FOR COLORECTAL SECONDARIES
    EKBERG, H
    TRANBERG, KG
    ANDERSSON, R
    LUNDSTEDT, C
    HAGERSTRAND, I
    RANSTAM, J
    BENGMARK, S
    [J]. BRITISH JOURNAL OF SURGERY, 1986, 73 (09) : 727 - 731
  • [6] Hepatic and extrahepatic colorectal metastases: When resectable, their localization does not matter, but their total number has a prognostic effect
    Elias, D
    Liberale, G
    Vernerey, D
    Pocard, M
    Ducreux, M
    Boige, V
    Malka, D
    Pignon, JP
    Lasser, P
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (11) : 900 - 909
  • [7] Results of R0 resection for colorectal liver metastases associated with extrahepatic disease
    Elias, D
    Sideris, L
    Pocard, M
    Ouellet, JF
    Boige, V
    Lasser, P
    Pignon, JP
    Ducreux, M
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (03) : 274 - 280
  • [8] Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases
    Elias, D
    Ouellet, JF
    Bellon, N
    Pignon, JP
    Pocard, M
    Lasser, P
    [J]. BRITISH JOURNAL OF SURGERY, 2003, 90 (05) : 567 - 574
  • [9] Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET)
    Fernandez, FG
    Drebin, JA
    Linehan, DC
    Dehdashti, F
    Siegel, BA
    Strasberg, SM
    [J]. ANNALS OF SURGERY, 2004, 240 (03) : 438 - 447
  • [10] Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer - Analysis of 1001 consecutive cases
    Fong, Y
    Fortner, J
    Sun, RL
    Brennan, MF
    Blumgart, LH
    [J]. ANNALS OF SURGERY, 1999, 230 (03) : 309 - 318